Catechol-O-methyltransferase modulation of cortisol secretion in psychiatrically at-risk and healthy adolescents

Psychiatric Genetics

Volumn 20, Issue 4, 2010, Pages 166-170

  Walder, Deborah J ^a   Trotman, Hanan D ^b   Cubells, Joseph F ^b   Brasfield, Joy ^b   Tang, Yi Lang ^b   Walker, Elaine F ^b  

^a CITY UNIVERSITY OF NEW YORK   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Catechol o methyltransferase; cortisol; genetic; hypothalamic pituitary adrenal axis; psychosis; risk; schizophrenia; stress

Indexed keywords

CATECHOL METHYLTRANSFERASE; HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; FOLLOW UP; GENOTYPE; HETEROZYGOTE; HOMOZYGOSITY; HOMOZYGOTE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROMODULATION; PRIORITY JOURNAL; PROTEIN FUNCTION; RISK ASSESSMENT; RISK FACTOR; SALIVA LEVEL; SCHOOL CHILD; STEROID RELEASE; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; HEALTH; METABOLISM; SALIVA; SECRETION (PROCESS);

ADOLESCENT; CATECHOL O-METHYLTRANSFERASE; CHILD; GENETIC PREDISPOSITION TO DISEASE; HEALTH; HUMANS; HYDROCORTISONE; MENTAL DISORDERS; RISK FACTORS; SALIVA;

EID: 77954888402     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e32833a1ff3     Document Type: Article

References (24)

1. First MB, Spitzer RL, Gibbon M, Williams BW (1998). Structured clinical interview for the DSM-IV Axis I disorders, patient edition. (SCID I). Washington, D.C.: American Psychiatric Press, Inc.
2. Jabbi M, Kema IP, van der Pompe G, te Meerman GJ, Ormel J, den Boer JA (2007). Catechol-o-methyltransferase polymorphism and susceptibility to major depressive disorder modulates psychological stress response. Psychiatr Genet 17:183-193.
3. Kenny FM, Preeyasombat C, Migeon CJ (1966). Cortisol production rate. II. Normal infants, children, and adults. Pediatrics 37:34-42.
4. Kiess W, Meidert A, Dressendorfer RA, Schriever K, Kessler U, Konig A, et al. (1995). Salivary cortisol levels throughout childhood and adolescence: relation with age, pubertal stage, and weight. Pediatr Res 37 (4 Pt 1): 502-506.
5. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
6. Laruelle M (2000). The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 31:371-384.
7. Linkowski P, Van Onderbergen A, Kerkhofs M, Bosson D, Mendlewicz J, Van Cauter E (1993). Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am J Physiol 264:173-181.
8. Lupien SJ,Wilkinson CW, Briere S, Menard C, Ng Ying Kin NM, Nair NP (2002). The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 27:401-416.
9. Mannisto PT, Kaakkola S (1999). Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
10. Mittal VA, Dhruv S, Tessner KD, Walder DJ, Walker EF (2007). The relations among putative biorisk markers in schizotypal adolescents: minor physical anomalies, movement abnormalities, and salivary cortisol. Biol Psychiatry 61:1179-1186.
11. Oswald LM, McCaul M, Choi L, Yang X, Wand GS (2004). Catechol- Omethyltransferase polymorphism alters hypothalamic-pituitary-adrenal axis responses to naloxone: a preliminary report. Biol Psychiatry 55:102-105.
12. Pfhol B, Blum N, Zimmerman M (1997). Structured Interview for DSM-IV Personality: SIDP-IV. Washington, DC: American Psychiatric Press, Inc.
13. Rylander-Rudqvist T, Hakansson N, Tybring G, Wolk A (2006). Quality and quantity of saliva DNA obtained from the self-administrated oragene method-a pilot study on the cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 15:1742-1745.
14. Smolka MN, Schumann G,Wrase J, Grusser SM, Flor H, Mann K, et al. (2005). Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. J Neurosci 25:836-842.
15. Sowell ER, Thompson PM, Toga AW (2007). Mapping adolescent brain maturation using structural magnetic resonance imaging. In: Romer D, Walker EF, editors. Adolescent psychopathology and the developing brain: integrating brain and prevention science. New York, NY: Oxford University Press. pp. 55-84.
16. Stefanis NC, Henquet C, Avramopoulos D, Smyrnis N, Evdokimidis I, Myin-Germeys I, et al. (2007). COMT Val158Met moderation of stressinduced psychosis. Psychol Med 37:1651-1656.
17. Trotman H, McMillan A, Walker E (2006). Cognitive function and symptoms in adolescents with schizotypal personality disorder. Schizophr Bull 32: 489-497.
18. Van Os J, Hanssen M, Bak M, Bijl RV, VolleberghW(2003). Do urbanicity and familial liability coparticipate in causing psychosis? Am J Psychiatry 160:477-482.
19. Van Winkel R, Henquet C, Rosa A, Papiol S, Fananas L, De Hert M, et al. (2008). Evidence that the COMT (Val158Met) polymorphism moderates sensitivity to stress in psychosis: an experience-sampling study. Am J Med Genet Part B: Neuropsychiatr Genet 147:10-17.
20. Wajs-Kuto E, De Beeck LO, Rooman RP, Caju MV (1999). Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls. Eur J Endocrinol 141:579-584.
21. Walker EF (2002). Adolescent neurodevelopment and psychopathology. Curr Dir in Psychol Sci 11:24-28.
22. Walker EF, Diforio D (1997). Schizophrenia: a neural diathesis-stress model. Psychol Rev 104:667-685.
23. Walker EF, Walder DJ, Reynolds F (2001). Developmental changes in cortisol secretion in normal and at-risk youth. Dev Psychopathol 13:721-732.
24. Zubieta J-K, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, et al. (2003). COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243.